Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HATAKABB Anti-Cough Mouth Spray vs Triamcinolone Mouth Spray for Recurrent Aphthous Stomatitis
TCTR20251229020Phase 4Not yet recruiting
- Sponsor
- Faculty of Dentistry, Chiang Mai University
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in aphthosis (RAS), sponsored by Faculty of Dentistry, Chiang Mai University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on TCTR20251229020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251229020.